- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Report predicts strong PET growth
A report by Frost & Sullivan predicts that positron emissiontomography's share of the worldwide market for cancer imagingand therapy equipment will grow rapidly in coming years. PET revenues will constitute 15% of the total market for suchequipment
A report by Frost & Sullivan predicts that positron emissiontomography's share of the worldwide market for cancer imagingand therapy equipment will grow rapidly in coming years.
PET revenues will constitute 15% of the total market for suchequipment by 2000, compared to 1% in 1993. PET's share of revenuesin the cancer imaging and therapy equipment market at that timewill match that of CT, which is expected to decline to 15%, comparedto 24% in 1993.
The market as a whole will grow at a 7% compound annual rate,from $2.74 billion in 1993 to $4.44 billion in 2000, accordingto the report, entitled World Cancer Diagnostic Imaging and TherapeuticEquipment Markets.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
